Almaral
A Strategic Partner For Growth-Driven Biotech Ventures

Behind every biotech breakthrough is a spark of ambition ignited in the lab. Yet, turning discoveries into global impact is an arduous journey that requires more than funding; it calls for a partner with vision, resilience and steadfast commitment.

Almaral embodies this role as a strategic ally for growth-driven biotech and life sciences ventures. Its approach feels more like a mentor’s steady hand than an investor’s financial backing. The unconventional VC firm is dedicated to elevating every biotech innovation to its fullest potential.

Where many investors stop at writing a check, that is merely the beginning for Almaral. It steps into the trenches with early-stage ventures, offering deep expertise in strategic planning, market positioning and regulatory landscapes. Working alongside biotech founders allows it to translate great ideas into actions to tackle real-world challenges.

The investment process is highly streamlined. Potential ventures are rigorously evaluated on product-market alignment, team strength, technological advancement and market risks. Only the startups that meet these stringent criteria benefit from Almaral’s hands-on guidance. Once onboard, it doesn’t just outline a vision—it crafts practical, detailed roadmaps to propel startups through complex regulatory and commercial environments.

“We invest in people as much as we do in ideas,” says Maria Severina, founder and CEO. “We dedicate ourselves to the companies we believe in, nurturing innovations that can improve lives worldwide.”

Assuming directorial roles on the boards of the companies it invests in, Almaral offers direct guidance and seasoned oversight, acting as the co-navigator in the journey from ideation to realisation and expansion. A comprehensive support system makes the firm a one-stop shop for biotech companies aiming to push the boundaries of what’s possible.

The Teamwork behind the Triumph

Twenty-seven years as CEO of an in vitro diagnostics company and two successful exits have led Severina to cultivate a deep-seated passion for innovation. When she co-founded Almaral with her husband, Alex Michine, who now serves as chairman of the board, their goal was to become the hands-on partner every visionary founder hopes to find.

Today, the Almaral team is as diverse as it is devoted. Experts from across the scientific, strategic, marketing and legal worlds each bring something essential to the table. While scientific advisors collaborate directly with startups to enhance research methodologies and explore the potential of new technologies, marketing specialists design strategies that connect clinicians and patients. Legal experts reinforce this support by skillfully guiding companies through the regulatory landscape and mitigating risks.

Three-Phase Blueprint for Building Stability and Long-Term Success

With purpose-driven strategies designed to keep pace with immediate needs and long-term aspirations, Almaral ensures that every company is positioned for sustainable growth, industry leadership and the realisation of their ultimate vision.

Laying the Foundation: The priority is establishing a robust foundation that startups can rely on for sustainable growth. In each board meeting, Almaral thoroughly reviews detailed reports on recent sales achievements and operational milestones presented by CEOs and CTOs. This keeps board members informed and ensures that decisions are anchored in up-to-date insights. Leveraging these findings, Almaral proactively identifies potential challenges, providing startups with strategic guidance to navigate the early hurdles of the market. Addressing bottlenecks before they become obstacles also empowers each company with the resilience and stability needed to thrive amid market pressures and grow with confidence.

Fuelling Expansion: When the time is right, Almaral guides the startups towards purposeful scaling that amplifies their reach and impact. Identifying new market opportunities and refining product offerings broadens each company’s footprint in ways that align with their strengths. Almaral also provides strategic foresight by developing early exit strategies, enabling startups to capture long-term value as they scale. The strategy supports sustainable growth without compromising on their vision.

Championing Innovation: A thoughtful approach to growth is essential because establishing a solid market position is a mark of true innovation in a field as dynamic as biotech. Almaral’s board operates much like a vigilant helicopter, hovering when the journey is smooth and prepared to land swiftly when challenges arise. With Almaral’s support for strategic expansion, startups have the resources needed to pursue cutting-edge research and breakthroughs that redefine industry standards. Helping startups take bold strides into uncharted territories assures they are not just keeping up with trends but setting new ones.

Scripting Stories of Successful Ventures

When Genomill, a pioneering Finnish health technology firm, faced significant hurdles in scaling its revolutionary liquid biopsy technology, Geno1, the path forward was far from clear.

Despite Geno1’s potential to reshape cancer diagnostics with cost-effective, high-performance solutions, achieving widespread market adoption proved challenging. At this critical juncture, Almaral came on the scene, offering substantial investment and strategic guidance needed to navigate the complexities.

“We saw a brilliant team and a transformative innovation in Genomill,” shares Severina. “Our goal wasn’t just to invest but to play an active role in turning their vision into a global success story.”

Today, Almaral and Genomill are allies with a shared vision—to reimagine the landscape of cancer diagnostics and make life-saving technology accessible to patients worldwide.

“It’s been a delight to work with Almaral,” said Jussi Pyysalo, Fepod’s CEO. “Their direct and honest communication, combined with a strong vision for achievable business targets, makes them the kind of partner every entrepreneur should have on their side. The partnership’s impact was felt immediately. From the outset, Almaral’s clear and direct approach stood out," Pyysalo recalled. “After our initial discussions, everything moved swiftly - communication was transparent, and our collaboration unfolded effortlessly. If I had to describe Almaral in three words, they would be— accomplished, straightforward and transparent.”

Living Up to the Promise of Personalised Support

Almaral believes true growth lies in tackling the finer points; the operational and strategic pivots that drive momentum but are often overlooked. Each of its engagements is an opportunity to amplify what makes a startup unique and to identify hidden opportunities that can unlock its full potential.

Whether refining hiring strategies for a high-growth phase or fine-tuning a market entry plan, Almaral’s approach addresses each company’s specific needs, helping them move from promising to unstoppable.

As Tamara Alagirova, CEO of Moncyte Health, a diagnostic biotech startup, stated, “Through our collaboration with Almaral, we sought expert insights into how to enter the market with a new health tech innovation and how to strategically carry out commercialisation efforts. The assistance we received has been very positive and diverse."

This level of support, achieved through close, consistent communication, has made Almaral’s name synonymous with trust and achievement in the biotech landscape. For those daring to transform the future of biotech, Almaral is the ally that turns ambition into achievement, charting a path forward with insight and integrity